Remebot, a neurosurgical robotic system, has undergone 20 years of independent research and clinical trials totaling tens of thousands of cases. It is the first domestically produced neurosurgical robotic system successfully applied in clinical settings, the first to accomplish remote surgery, and the first to receive certification from the NMPA (National Medical Products Administration). It stands as the leader in the domestic and even the entire surgical robotics industry.
Leveraging medical imaging scanning, 3D visualization, multimodal image fusion, and precise planning of puncture pathways, Remebot's technology helps avoid the trauma associated with traditional craniotomies. It enables precise control and repair of intracranial lesions and neural structures, establishing new physiological balance. The average duration of the entire surgery is 30 minutes, with a positioning accuracy of 0.5 millimeters and an incision size of only 2 millimeters. Patients can typically be discharged after 2 to 3 days of postoperative observation. Remebot embodies features of minimally invasive, precise, and efficient procedures.
For Brain surgeries, Remebot combines CT and MRI images, allowing doctors to plan the best surgical puncture pathway by observing the patient's multi-modal head images.
For Eye surgeries, Remebot conducts spatial mapping, tracking real-time movement, and ensuring that the robotic arm moves along the planned pathway to the surgical location.
For Hand surgeries, it accurately positions the surgical puncture location planned by the doctor while serving as a multifunctional surgical operating table.